The largest genetic study to date into long-term health conditions of later life has identified opportunities for new ways to treat multiple overlapping conditions. Currently, nine million people in the UK live with two or more long-term conditions at the same time (multimorbidity). Their treatment accounts for… Read More
Therapies that deliver hydrogen sulphide to cells could one day become the basis of new treatments for obesity and related diseases, new research has concluded. Mounting evidence suggests that hydrogen sulphide plays an important role in the liver. Previous research shows that tiny amounts of hydrogen… Read More
The discovery of a new regulator affecting immune cells could lead to new treatments to reduce inflammation in diseases including arthritis and severe Covid-19. A large research collaboration, led by the University of Exeter’s MRC Centre for Medical Mycology, has focused on how immune cells sense… Read More
A UK-based study will investigate whether a common anti-viral medication could double up as a treatment for long Covid. The project involves teams from the University Hospitals of Derby and Burton NHS Foundation Trust and the University of Exeter, in collaboration with Gilead Sciences. Read More
A team of scientists have discovered that modification of a gene in the brain can reduce anxiety levels, offering an exciting novel drug target for anxiety disorders. The discovery, led by researchers at the Universities of Bristol and Exeter in the UK, is published in Nature… Read More
